Plus Therapeutics (PSTV) Revenue Growth (1y) (2012 - 2026)
Plus Therapeutics (PSTV) Revenue Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
37.90% |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Plus Therapeutics |
34.26 Mn |
19.15 Mn |
- |
-2.93% |
| Date | Value |
|---|
| Mar 31, 2026 |
-2.93% |
| Dec 31, 2025 |
-3.19% |
| Sep 30, 2025 |
-4.05% |
| Jun 30, 2025 |
8.68% |
| Mar 31, 2025 |
-36.85% |
| Dec 31, 2024 |
7.54% |
| Sep 30, 2024 |
-66.91% |
| Jun 30, 2024 |
-31.01% |
| Mar 31, 2024 |
235.40% |
| Dec 31, 2023 |
933.86% |
| Sep 30, 2023 |
5,927.40% |
| Mar 31, 2019 |
-3.83% |
| Dec 31, 2018 |
114.80% |
| Sep 30, 2018 |
83.73% |
| Jun 30, 2018 |
-31.89% |
| Mar 31, 2018 |
23.69% |
| Dec 31, 2017 |
-54.84% |
| Sep 30, 2017 |
-36.11% |
| Jun 30, 2017 |
-13.94% |
| Mar 31, 2017 |
-55.66% |
